Stay updated on CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial

Sign up to get notified when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:47:34.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:21:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added related topic links for Schizophrenia and MedlinePlus Genetics to the page's related topics.
    Difference
    0.1%
    Check dated 2026-04-09T20:45:49.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The 'Schizophrenia' condition label and the 'MedlinePlus Genetics' related topics section were removed from the page. This reduces key contextual cues about the study's condition and related resources.
    Difference
    0.1%
    Check dated 2026-04-02T15:19:22.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added related topics Schizophrenia and MedlinePlus Genetics to the study details page.
    Difference
    0.1%
    Check dated 2026-03-26T11:21:12.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Version v3.5.0 was added and the topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed (Revision: v3.4.3). The core study details on the page remain unchanged.
    Difference
    0.2%
    Check dated 2026-03-19T04:51:49.000Z thumbnail image

Stay in the know with updates to CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CVL-231 in Schizophrenia: 10 and 30 mg Doses Clinical Trial page.